News About: Pharm. Industry
Drug industry to oppose substitutive dispensing restriction only for proven drugs of bio-equivalency
The pharmaceutical industry strongly opposed, as saying "Nonsense".
against the issue of restricting the substitutive dispensing only for the drugs already proved with its bio-equivalency test in the negotiation betw...
Korea Research Institute of Chemistry conducted drug toxicokinetic test on Primates.
A drug toxicokinetic test on monkey has been conducted for the first time in Korea, providing a milestone in saving time and cost for the required preclinical studies of a new drug development.
The Safety Research...
Drug industry calls for common prescription drug list to remove.
The current pharmaceutical affairs law contains the drug list for about 600 most common prescription drugs, but the drug industry strongly called for this clause to be deleted in upcoming revision process of the same ...
Pharmaceutical technology to export U$380 million
The total technology sales to foreign multinational drug corporations recorded over U$380 million including the recent Yuhan's new technology export to Smithkline Beecham at U$100 million for YH1885, a new proton pump...
Yuhan sold technology YH1885 to SB at a hundred million dollar.
Yuhan has developed a new anti-peptic ulcer agent, YH1885 ( a proton-pump channel inhibitor) as one of the government's G7 projects and sold it out to Smithkline Beecham at U$100 million of its royalty. Two parties ma...
Increased returned-goods to raise tremendous business difficulties to drug industries.
Since implementation of the government medical and pharmacy role separating program many pharmacies have shut down their business operations, and the common prescription drug lists that were supposedly distributed alr...
Foreign multinational drug corporations to capture higher market shares
According to the KFDA published statistics, 20 top leading foreign multinational drug companies produced 1,072,341 million won of pharmaceutical products in 1999, which was 11.9% increase over the previous year of 957...
545 billion won of 2001 national budget to subsidy for settlement of medical/pharmacy reform program
The MOHW fixed the 2001 budget after ratification from the cabinet meeting at the total 6,274,900 million won, 38.6% increase over the previous year, which included 545 billion won for supporting to the regional medic...
Public advertising for OTC drugs to activate despite slow sales
Korea Advertising Data recently reported that 14 top pharmaceutical companies including Dong-A, CKD, Choongwe, Yuhan and Daewoong spent the total 100 billion won level of public advertising expenditures for their OTC ...
Drug industry in trouble with month-end credit collection.
The medical community's prolonged strike against the government medical reform plan has raised serious business management difficulties to medical institutes, resulting in postponement of their credit payment to drug ...
